JORANE BONHEUR: Open Payments
NPI 1043669245 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 16 payments from 10 companies in 2025. Trend: 2023 $383 · 2024 $343 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| CVRx, Inc. | 2 | $41 |
| Novo Nordisk Inc | 1 | $29 |
| Dexcom, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
Products named: FARXIGA, Kerendia, Barostim Neo System, Wegovy, Dexcom G6 Transmitter, JARDIANCE, AREXVY, Korlym.
Industry payments across NJ — which companies pay providers there.
